Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
Clinical trial NCT01497522 · COMPLETED
Trial details
- NCT number
- NCT01497522
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-02-01
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.